These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2146231)

  • 1. Multiple-dose, double-blind, placebo controlled intravenous tolerance and pharmacokinetic study of trospectomycin sulfate (U-63, 366F) in healthy male volunteers.
    Peters GR; Novak E; Batts DH; Bye A; Nichols DJ; Francom SF
    Int J Clin Pharmacol Ther Toxicol; 1990 Sep; 28(9):361-8. PubMed ID: 2146231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and pharmacokinetics of intravenously administered trospectomycin sulfate.
    Novak E; Griffith DL; Paxton LM; Metzler CM; Bye A
    Clin Ther; 1990; 12(3):269-80. PubMed ID: 2143104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human safety and pharmacokinetics of a single intramuscular dose of a novel spectinomycin analog, trospectomycin (U-63,366F).
    Novak E; Paxton LM; Bye A; Patel R; Zurenko GE; Francom SF
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2342-7. PubMed ID: 2150907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and pharmacologic activity of a new nitrate ester, ITF 296, after intravenous administration in healthy volunteers.
    Sardina M; Love R; Mizrahi J; Monzani V; Bianchini C
    J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S72-9. PubMed ID: 8839230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
    Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
    Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution and disposition of trospectomycin sulfate in the in vivo rat, perfused rat liver, and cultured rat hepatocytes.
    Cox JW; Dring LG; Ginsberg LC; Larson PG; Constable DA; Ulrich RG
    Drug Metab Dispos; 1990; 18(5):726-31. PubMed ID: 1981727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and tolerance of single- and multiple-dose oral or intravenous linezolid, an oxazolidinone antibiotic, in healthy volunteers.
    Stalker DJ; Jungbluth GL; Hopkins NK; Batts DH
    J Antimicrob Chemother; 2003 May; 51(5):1239-46. PubMed ID: 12668582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of gonococcal infections with a single 250 mg intramuscular injection of trospectomycin sulphate vs ceftriaxone sodium.
    Mroczkowski TF; Millikan LE; Martin DH; Leonik KJ
    Drugs Exp Clin Res; 1993; 19(1):41-6. PubMed ID: 8223139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and fate of [3H]trospectomycin sulfate, a novel aminocyclitol antibiotic, in male and female dogs and rabbits. Allometric scaling with human.
    Nichols DJ; Burrows M; Bye A; Constable DA; Dring LG; Jeffrey P
    Drug Metab Dispos; 1991; 19(4):781-6. PubMed ID: 1680655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
    Kisicki JC; Fiske K; Lyne A
    Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety and tolerability of single intravenous doses of lubeluzole (Prosynap) in healthy volunteers.
    Hantson L; Tritsmans L; Crabbé R; Gheuens J; Van Rooy P
    Int J Clin Pharmacol Ther; 1997 Nov; 35(11):491-5. PubMed ID: 9401829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and pharmacokinetics of multiple 750-milligram doses of intravenous levofloxacin in healthy volunteers.
    Chow AT; Fowler C; Williams RR; Morgan N; Kaminski S; Natarajan J
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2122-5. PubMed ID: 11408234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two single-center, double-blind, randomized, placebo-controlled, phase I studies to investigate the tolerability and pharmacokinetics of CH-1504, an antifolate, in healthy male subjects.
    Mant T; Jurcevic S; Szakacs C; Adams L; Boland J; Hewitt LA
    Clin Ther; 2008 Jan; 30(1):131-42. PubMed ID: 18343249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and fate of 3H-trospectomycin sulphate, a novel aminocyclitol antibiotic, in male and female rats.
    Nichols DJ; Burrows M; Bye A; Constable DA; Dring LG; Jeffrey P
    Xenobiotica; 1991 Jul; 21(7):827-37. PubMed ID: 1837966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of trospectomycin sulphate in healthy subjects after single intravenous and intramuscular doses.
    Nichols DJ; Bye A; Novak E
    Br J Clin Pharmacol; 1991 Aug; 32(2):255-7. PubMed ID: 1834145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB; Dowell JA; Pratt RD
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analgesic effects of intranasal butorphanol tartrate administered via a unit-dose device in the dental impaction pain model: a randomized, double-blind, placebo-controlled, parallel-group study.
    Wermeling DP; Grant GM; Lee A; Alexander N; Rudy AC
    Clin Ther; 2005 Apr; 27(4):430-40. PubMed ID: 15922816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the efficacy and safety of intravenous conivaptan in patients with euvolaemic hyponatraemia: subgroup analysis of a randomized, controlled study.
    Verbalis JG; Zeltser D; Smith N; Barve A; Andoh M
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):159-68. PubMed ID: 18034777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects.
    O'Farrell AM; van Vliet A; Abou Farha K; Cherrington JM; Campbell DA; Li X; Hanway D; Li J; Guler HP
    Clin Ther; 2007 Aug; 29(8):1692-705. PubMed ID: 17919550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.